Sree Kant is an experienced biotech executive, and company builder with more than 20 years in life sciences and healthcare. He currently serves as the Founder and CEO of BAKX Therapeutics. Previously, Sree has headed the Investments and Partnerships function at Life Biosciences, led early partnering strategy for Pfizer, was a Principal at the Boston Consulting Group, was a founding member of India’s first preventative, managed health company, and started his career at Ranbaxy labs in New Delhi and London. Sree has an MBA from the Indian Institute of Management, and an MPH from the Harvard School of Public Health.
In recent years, numerous biotech companies have adopted a portfolio approach with the promise that this strategy both diversifies risk and increases shots on goal. Though initially strong, the reception by the investor community is finally beginning to weaken.